About
About
Contact Us
Pipeline
Pipeline
Sirexatamab (DKN-01) Programs
Gastric Cancer
Colorectal Cancer
Endometrial Cancer
Prostate Cancer
Lung Cancer
FL-301 (NBL-015) Program
FL-501 Program
Science
Science
DKK1
Sirexatamab (DKN-01)
Claudin18.2
GDF-15
Patients
Patients
Expanded access
Careers
Investors
Investors
Stock Information
News Releases
Presentations & Events
Financial Information
Corporate Governance
Information Request
Sirexatamab (DKN-01)
programs
Sirexatamab (DKN-01):
Anti-DKK1 antibody
Gastric
Sirexatamab (DKN-01):
Anti-DKK1 antibody
Colorectal
Sirexatamab (DKN-01):
Anti-DKK1 antibody
Endometrial
Sirexatamab (DKN-01):
Anti-DKK1 antibody
Prostate
Sirexatamab (DKN-01):
Anti-DKK1 antibody
Lung
